Metabolic complications of citrate anticoagulation in continuous renal replacement therapy (crrt): a delphi consensus on indications, monitoring and management
Authors' conclusion
These consensus statements support the use of RCA during CRRT in critically ill patients with impaired citrate metabolism and provide practical guidance for monitoring and management of metabolic complications.
Study context
- Population
- Critically ill patients receiving continuous renal replacement therapy (CRRT) with regional citrate anticoagulation (RCA), including those with impaired citrate metabolism23 completed all rounds
- Participants
- 29 patients
- Outcome
- Consensus statements
Methodological detailspredefined protocol, CREDES checklist, three iterative survey rounds, international expert panel
- Predefined protocol
- CREDES checklist
- Three iterative survey rounds
- International expert panel
Recommendations
As reported in the abstract
Consensus achieved on statements
22
Original publication
Metabolic complications of citrate anticoagulation in continuous renal replacement therapy (crrt): a delphi consensus on indications, monitoring and management. Crit Care. Published 13 May 2026. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →